losartan-potassium and Nail-Diseases

losartan-potassium has been researched along with Nail-Diseases* in 1 studies

Other Studies

1 other study(ies) available for losartan-potassium and Nail-Diseases

Article	Year
Treatment of dyskeratosis congenita with granulocyte colony-stimulating factor and erythropoietin. British journal of haematology, 1997, Volume: 97, Issue:2 Aplastic anaemia is both frequent and difficult to manage in patients with dyskeratosis congenita (DC). We recently treated a 23-year-old male for a year with granulocyte colony-stimulating factor (G-CSF) and erythropoietin (Ep), with an excellent neutrophil response, and a transient effect on haemoglobin levels. G-CSF alone or combined with other cytokines may provide at least a partial effect in pancytopenic patients with DC. Topics: Adult; Anemia, Aplastic; Erythropoietin; Granulocyte Colony-Stimulating Factor; Humans; Hyperpigmentation; Male; Nail Diseases; Syndrome; X Chromosome	1997

Article

Year

Treatment of dyskeratosis congenita with granulocyte colony-stimulating factor and erythropoietin.

British journal of haematology, 1997, Volume: 97, Issue:2

Aplastic anaemia is both frequent and difficult to manage in patients with dyskeratosis congenita (DC). We recently treated a 23-year-old male for a year with granulocyte colony-stimulating factor (G-CSF) and erythropoietin (Ep), with an excellent neutrophil response, and a transient effect on haemoglobin levels. G-CSF alone or combined with other cytokines may provide at least a partial effect in pancytopenic patients with DC.

Topics: Adult; Anemia, Aplastic; Erythropoietin; Granulocyte Colony-Stimulating Factor; Humans; Hyperpigmentation; Male; Nail Diseases; Syndrome; X Chromosome

1997